Quit smoking and Injection site extravasation - from FDA reports

Summary

Injection site extravasation is reported only by a few people with Quit smoking. We study 3 people who have Injection site extravasation and Quit smoking from FDA . Find out below who they are, other conditions they have and drugs they take.

What to expect?

If you have Quit smoking and Injection site extravasation, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Quit smoking and Injection site extravasation

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 20, 2017

3 people who have Quit Smoking and Injection Site Extravasation are studied.


Number of reports submitted per year:

Would you have Injection site extravasation when you have Quit smoking?

Gender of people who have Quit Smoking and experience Injection Site Extravasation *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Quit Smoking and experience Injection Site Extravasation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Top co-existing conditions for these people *:

  • Gastroesophageal Reflux Disease (2 people, 66.67%)
  • Type 2 Diabetes (1 person, 33.33%)
  • Stress And Anxiety (1 person, 33.33%)
  • Polycystic Ovary Disease (1 person, 33.33%)
  • Blood Pressure Management (1 person, 33.33%)

Most common drugs for these people *:

  • Cymbalta (2 people, 66.67%)
  • Chantix (2 people, 66.67%)
  • Xanax (1 person, 33.33%)
  • Mucinex (1 person, 33.33%)
  • Byetta (1 person, 33.33%)

Top symptoms for these people *:

  • Insomnia (2 people, 66.67%)
  • Productive Cough (1 person, 33.33%)
  • Menopausal Symptoms (1 person, 33.33%)
  • Itching (1 person, 33.33%)
  • Back Pain (1 person, 33.33%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Injection site extravasation and Quit smoking?

Expand the study to include reports from both FDA and eHealthMe

Injection site extravasation and Quit smoking from FDA and eHealthMe reports

Quit Smoking

Quit smoking can be treated by Chantix, Bupropion hydrochloride, Wellbutrin, Wellbutrin sr, Zyban (latest reports from 70,050 Quit smoking patients)

Injection Site Extravasation

Injection site extravasation (flow of (blood or lymph) from injection site) has been reported by people with rheumatoid arthritis, type 2 diabetes, crohn's disease, psoriatic arthropathy, psoriasis (latest reports from 6,840 Injection site extravasation patients).

Browse all symptoms of Quit smoking

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Injection site extravasation

Injection site extravasation

Other conditions that could case Injection site extravasation

Injection site extravasation

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Quit smoking and Injection site extravasation.

Can you answer these questions?

More questions for: Quit smoking, Injection site extravasation

You may be interested in these reviews

More reviews for: Quit smoking, Injection site extravasation